IP Library Granted Patent US 11,589,748
Granted Patent B2
US 11,589,748 · App. 16/739,084 · Granted Feb 28, 2023

Implants using ultrasonic backscatter for sensing physiological conditions

Inventors: Michel M. Maharbiz (El Cerrito, CA); Jose M. Carmena (Berkeley, CA); Mekhail Anwar (San Francisco, CA); Burak A. Ozilgen (Berkeley, CA); Dongjin Seo (Albany, CA); Federica Fava (Berkeley, CA)
Assignee: The Regents of the University of California
A61B5/0031A61B5/076A61B5/686A61B6/4258A61B8/085A61B8/0808A61B8/0875A61B8/48A61N1/3605A61N1/3787A61N1/37205B06B1/06G01N27/327A61B2505/05A61B2560/0219A61B2562/028A61B2562/12A61M39/0208A61M2205/04A61M2205/825A61N1/0534A61N1/372A61N5/1071A61N2005/1087A61N2007/0021
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,589,748
App. No.
16/739,084
Granted
Feb 28, 2023
Kind
B2
Abstract

Described herein is an implantable device having a sensor configured to detect an amount of an analyte, a pH, a temperature, strain, or a pressure; and an ultrasonic transducer with a length of about 5 mm or less in the longest dimension, configured to receive current modulated based on the analyte amount, the pH, the temperature, or the pressure detected by the sensor, and emit an ultrasonic backscatter based on the received current. The implantable device can be implanted in a subject, such as an animal or a plant. Also described herein are systems including one or more implantable devices and an interrogator comprising one or more ultrasonic transducers configured to transmit ultrasonic waves to the one or more implantable devices or receive ultrasonic backscatter from the one or more implantable devices. Also described are methods of detecting an amount of an analyte, a pH, a temperature, a strain, or a pressure.

Claims (24)

1. An implantable device, comprising:

a sensor configured to detect a physiological signal; and

an ultrasonic transducer with a longest dimensional length of 5 mm or less, the ultrasonic transducer configured to receive ultrasonic waves that power the implantable device, receive a current modulated based on the physiological signal detected by the sensor, and emit a physiological-signal-dependent ultrasonic backscatter based on the current received by the ultrasonic transducer.

2. The implantable device of claim 1 , wherein the ultrasonic backscatter encodes a digitized signal.

3. The implantable device of claim 1 , wherein the ultrasonic transducer is configured to receive ultrasonic waves that power the implantable device.

4. The implantable device of claim 3 , wherein the ultrasonic transducer is configured to receive the ultrasonic waves from an interrogator comprising one or more ultrasonic transducers.

5. The implantable device of claim 1 , wherein the ultrasonic transducer is a bulk piezoelectric transducer, a piezoelectric micro-machined ultrasonic transducer (PMUT) or a capacitive micro-machined ultrasonic transducer (CMUT).

6. The implantable device of claim 1 , wherein the implantable device is 5 mm or less in length in the longest dimension.

7. The implantable device of claim 1 , wherein the volume of the implantable device is about 5 mm 3 or less.

8. The implantable device of claim 1 , wherein the implantable device further comprises an integrated circuit.

9. The implantable device of claim 8 , wherein the integrated circuit comprises a power circuit.

10. The implantable device of claim 8 , wherein the integrated circuit comprises a driver configured to provide a current to the sensor.

11. The implantable device of claim 8 , wherein the integrated circuit comprises a front end configured to receive a signal from the sensor.

12. The implantable device of claim 8 , wherein the integrated circuit comprises a digital circuit.

13. The implantable device of claim 12 , wherein the digital circuit is configured to operate a modulation circuit.

14. The implantable device of claim 13 , wherein the digital circuit is configured to transmit a digitized signal to the modulation circuit, wherein the digitized signal is based on the detected physiological signal.

15. The implantable device of claim 12 , wherein the integrated circuit comprises a memory that stores one or more programs for operating the implantable device.

16. The implantable device of claim 11 , wherein the digital circuit comprises a microcontroller.

17. The implantable device of claim 11 , wherein the digital circuit comprises a finite state machine.

18. The implantable device of claim 1 , wherein the implanted device is at least partially encapsulated by a biocompatible material.

19. The implantable device of claim 1 , wherein the implantable device comprises two or more sensors.

20. A system, comprising:

the implantable device of claim 1 ; and

an interrogator comprising one or more ultrasonic transducers configured to transmit the ultrasonic waves that power the implantable device, and receive the ultrasonic backscatter from the implantable device.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 2, 2020
From: MAHARBIZ, MICHEL M.; CARMENA, JOSE M.; ANWAR, MEKHAIL; OZILGEN, BURAK A.; SEO, DONGJIN; FAVA, FEDERICA
To: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
Reel/Frame 051984/0819 →
Continuity (6)
Continuation 16380944 · Apr 10, 2019
Continuation 16141930 · Sep 25, 2018
Continuation 15702301 · Sep 12, 2017
Continuation PCTUS2017041257 · Jul 7, 2017
Provisional Application 62359672 · Jul 7, 2016
Related Publication 20200324148A1 · Oct 15, 2020
Cited By (7)
US 12,233,269 US 12,239,408 US 12,268,463 US 12,357,835 US 12,375,925 US 12,446,795 US 12,538,131